Yarrow Bioscience Inc

YARW ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
SCHEDULE 13G Oct 7, 2026
SCHEDULE 13G Sep 17, 2026
8-K Sep 14, 2026 FORM 8-K
424B5 Sep 11, 2026 424B5
424B5 Sep 11, 2026 424B5
8-K Sep 10, 2026 FORM 8-K
EFFECT Aug 19, 2026
SCHEDULE 13G Aug 14, 2026
SCHEDULE 13G Aug 14, 2026
POS AM Aug 14, 2026 POS AM
8-K/A Aug 13, 2026 FORM 8-K/A
10-Q Aug 13, 2026 10-Q
SCHEDULE 13G/A Aug 13, 2026
SCHEDULE 13G/A Aug 7, 2026
SCHEDULE 13G Aug 7, 2026
SCHEDULE 13D Aug 5, 2026
SCHEDULE 13G Aug 4, 2026
SCHEDULE 13G Aug 3, 2026
SCHEDULE 13G Jul 30, 2026
4 Jul 30, 2026 OWNERSHIP DOCUMENT
8-K Jul 30, 2026 FORM 8-K
3 Jul 30, 2026 OWNERSHIP DOCUMENT
4 Jul 29, 2026 OWNERSHIP DOCUMENT
4 Jul 29, 2026 OWNERSHIP DOCUMENT
3 Jul 29, 2026 OWNERSHIP DOCUMENT
← Newer Page 1 of 28 · 677 filings Older →